The company’s financial report represents the seventh consecutive period of quarterly growth. RSB Spine CEO John A. Redmond attributes the company’s success to its distribution capabilities. The company’s products are distributed by Paradigm BioDevices.
RSB Spine offers an allograft flush-fit technology, which is unique to its market.
Read the release on RSB Spine.
Related Articles on RSB Spine:
RSB Spine Announces 145% Sales Increase in Q1
RSB Spine Reports 97% Sales Increase in 2010
RSB Spine’s InterPlate L-Ti Receives Clearance as an Anterior Lumbar Plate
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
